glp 1 agonists adverse effects of GLP-1 class drugs. Gastrointestinal issues are glp 1 drug side effects
Description
Here, we describe the discovery and characterization of the second incretin hormone, GLP-1

In this study, 422 participants who lost over 5% of initial body weight on a low-calorie diet were randomized to liraglutide 3.0 mg or placebo for 56 weeks

Persistent or severe vomiting or abdominal pain whilst on GLP-1 therapy may suggest pancreatitis and requires urgent medical attention
Other ongoing trials are also investigating the impact of tirzepatide on cardiovascular safety and efficacy

For GLP-1 receptor agonists as of April 2026, no true generic has entered the U.S

140,147,153,155,159 However, statins are known to exhibit high interindividual variability in terms of pharmacokinetics, and GLP-1 RA administration did not affect the lipid-lowering effect of statins in clinical studies, indicating minimal clinical significance
